Marimed (MRMD) Return on Capital Employed (2012 - 2026)

Marimed (MRMD) has 15 years of Return on Capital Employed data on file, last reported at 1.2% in Q1 2026.

• On a quarterly basis, Return on Capital Employed fell 115.0% year-over-year to 1.2% in Q1 2026; TTM through Mar 2026 was 1.2%, a 115.0% decrease from a year earlier, with the FY2025 full-year figure at 1.94%, down 366.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 1.2%, up from 6.38% in the prior quarter.
• Over the last five years, Return on Capital Employed for MRMD reached as high as 28.02% in Q1 2022 and fell as low as 6.38% in Q4 2025.
• Historically, Return on Capital Employed has averaged 7.78% across 5 years, with a median of 6.9% in 2024.
• Across the five-year window, Return on Capital Employed sank 2190 bps in 2022 and tumbled 115 bps in 2026, its largest moves.
• Year by year, Return on Capital Employed stood at 16.7% in 2022, then slumped by 47 bps to 8.85% in 2023, then slumped by 80 bps to 1.79% in 2024, then tumbled by 457 bps to 6.38% in 2025, then jumped by 81 bps to 1.2% in 2026.
• Per Business Quant data, the three most recent Return on Capital Employed figures were 1.2% in Q1 2026, 6.38% in Q4 2025, and 0.79% in Q3 2025.